Skip to main content
Fig. 1 | Journal of Hematology & Oncology

Fig. 1

From: A novel CD123-targeted therapeutic peptide loaded by micellar delivery system combats refractory acute myeloid leukemia

Fig. 1

A Affinity of mPO-6 to MOLM-13 cells incubated at 0.1 and 0.5 μM for 0.5 h. B Images of mPO-6 bound with MOLM-13 cells at 0.1 μM for 0.5 h obtained from the laser confocal microscopy. C Effects of mPO-6 on the cell viability in the presence of IL-3 (n = 4). D and E Effects of mPO-6 on the cell viability of the primary AML blasts. F The treatment of mPO-6 prolonged the refractory AML mice median survival significantly (n = 14). *P < 0.05, **P < 0.01

Back to article page